Crescent Pharma Limited has issued a recall of one batch of Ramipril 10mg capsules. The recall is being carried out as a precautionary measure following the identification of a potential error at the manufacturing site. The Medicines and Healthcare products Regulatory Agency (MHRA) has been notified of the recall.
Regulatory UpdatesAug 23, 2026•1 min read
Crescent Pharma Recalls Ramipril 10mg Capsules Batch
Crescent Pharma Limited is recalling a batch of Ramipril 10mg capsules as a precaution due to a possible manufacturing error.
Compiled by the PharmaCountry team · Source: MHRA
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating